This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its spirocyclic structure makes it a valuable building block for developing molecules with potential therapeutic properties. It is often employed in the preparation of compounds targeting neurological disorders, including depression and anxiety, due to its ability to modulate specific receptors in the brain. Additionally, it is used in drug discovery programs to create novel chemical entities with enhanced bioavailability and stability. The BOC (tert-butyloxycarbonyl) protecting group in the molecule allows for selective reactions, making it a versatile tool in organic synthesis.